To know the impact of COVID-19 On Immunotherapy Drug Market 2020 By Therapy Area Analysis (Cancer, Solid Tumor, Malignant, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) By Type of Drugs Analysis (Monoclonal Antibodies, Adult Vaccines, Preventive Vaccines, Therapeutic Vaccines, Checkpoint Inhibitors, Alpha & BetaInterferons, Interleukins, Others) Forecast to 2025 Market
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027
Immunotherapy Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025. Increasing geriatric population and adoption of targeted therapies with lesser side effects are major key factor which drives the Immunotherapy Drug Market.
Some Key Players of the Immunotherapy Drug Market
Immunotherapy Drug Market reports cover prominent top players are,
- F. Hoffmann-La Roche AG
- GlaxoSmithKline Inc.
- Amgen, Inc
- Merck & Co., Inc.
- Bristol-Myers Squibb
- Novartis International AG
- Johnson & Johnson
- AstraZeneca Plc
- OPKO Health, Inc.
- Myriad Genetics Inc
- Koninklijke Philips N.V
- Illumina, Inc.
- Abbott, PerkinElmer, Inc
- Genomic Health, Inc.
- Sysmex Corporation
- AbbVie, Inc.
- Eli Lilly and Company
- Alder Biopharmaceuticals
- Boehringer Ingelheim
- Argos Therapeutics
- CTI BioPharma
- AVAX Technologies
- ADC Therapeutics
- Aduro Biotech
- Acorda Therapeutics
- Bavarian Nordic.
Scope Of Market Reports –
Immunotherapy is a type of cancer treatment that enhances the body’s natural defenses to fight the cancerous tissues. In this therapy substances made by the body or in a laboratory are used to improve or restore immune system function.There are several types of immunotherapy such as Monoclonal antibodies, Non-specific immunotherapies,Oncolytic virus therapy, T-cell therapy and Cancer vaccines.The drug used for this therapy is called Immunotherapy Drugs. Immunotherapy drugs are designed to alert the immune system about mutated cells so it can find and destroy them easily. Such as, Ipilimumab, Atizolizumab, Avelumab, Pembrolizumab and Nivolumab. Some Side effects of Immunotherapy are Fatigue, Fever, Chills, Weakness, Nausea, Vomiting, Dizziness, High or Low Blood Pressure, Headache, Diarrhea and Cough.
Immunotherapy Drug Market is segmented on the basis of Therapy Area, Types of Drugs, End user and Geography. Based upon Therapy DrugImmunotherapy Drug Market is classified as Cancer, Autoimmune & inflammatory diseases, Infectious Diseases and Others. Based on the type of DrugImmunotherapy Drug Market is classified into Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors,Interferons, Alpha & Beta Interleukins and Others. On the basis of End users Autologous Stem Cell and Non Stem Based therapies Market is classified into Hospitals, Clinics and Others.
The regions covered in Immunotherapy Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Immunotherapy Drug Market reports cover prominent players like F. Hoffmann-La Roche AG, GlaxoSmithKline Inc., Amgen, Inc., Merck & Co., Inc., Bristol-Myers Squibb, Novartis International AG, Johnson & Johnson, AstraZeneca Plc,OPKO Health, Inc., Myriad Genetics Inc, Koninklijke Philips N.V, Qiagen, Illumina, Inc., Abbott, PerkinElmer, Inc., Genomic Health, Inc., Sysmex Corporation, AbbVie, Inc., Eli Lilly and Company, Alder Biopharmaceuticals, ChemoCentryx, Boehringer Ingelheim,Argos Therapeutics, Agenus, CTI BioPharma, AVAX Technologies, ADC Therapeutics, Biothera, Biogen, Aduro Biotech, Acorda Therapeutics,Advaxis, CoherusBioSciences and Bavarian Nordic.
Market Dynamics –
Rising adoption of targeted therapies with fewer side effects, quicker drug approval processes and highest prevalence rate of lifestyle diseases such as atherosclerosis, heart disease, stroke, obesity, type 2 diabetes and diseases associated with smoking and alcohol and drug abuse is anticipated to fuel the immunotherapy drugs market growth. Moreover, Materialization of biosimilars is another driving factor for the immunotherapy drugs market.However, the high cost of immunotherapy treatment such as Current checkpoint inhibitors each have a price approximate $150,000 a year. A combination of Yervoy and Opdivo approved by FDA(Food and Drug Administration) for advanced or impossible tumor has a cost of $256,000 per one year for patients who respond to the treatment. Thus high cost of drug can affect the growth of immunotherapy drug market. Nonetheless, growing opportunities in the emerging markets and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy.
Regional Analysis –
North America is probable to attain the largest share of the Immunotherapy Drug Market in terms of revenue and expected to hold the position followed by Europe region.This is due to favorable government initiatives, increased expenditure on Research and Development, personalized medicineand availability of technologically advanced health care research framework. Asia Pacific is likely to achieve a high growth rate of the immunotherapy drugs market in the next few years due to development of health care infrastructure, high disposable income, rise in health and hygiene related awareness, large untapped market base, and economic development.Prosperous middle class willing to spend on quality healthcare products is driving the Immunotherapy drug Market.Furthermore, increased awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.
Key Benefits –
Immunotherapy Drug Market report covers in depth historical and forecast analysis.
Immunotherapy Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Immunotherapy Drug Marketreport helps to identify opportunities in market place.
Immunotherapy Drug Market report covers extensive analysis of emerging trends and competitive landscape.
Immunotherapy Drug Market Segmentation –
By Therapy Area Analysis -Cancer, Solid Tumor, Malignant, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others
By Type of Drugs Analysis- Monoclonal Antibodies, Adult Vaccines, Preventive Vaccines, Therapeutic Vaccines, Checkpoint Inhibitors, Alpha & BetaInterferons, Interleukins, Others
By End User Analysis- Hospitals, Clinics, Others
By Regional & Country Analysis
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Frequently Asked Questions (FAQ) :
Interested in this report?
Immunotherapy Drug Market | Development Status and Outlook